| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.5 | 2.3 | 2.7 | 1.9 | 2.0 | 3.3 | +62.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 1.5 | 2.3 | 2.8 | 2.0 | 2.1 | 3.3 | +54.6% | |
| Operating income | (1.5) | (3.0) | (4.1) | (2.3) | (2.1) | (3.0) | −40.5% | |
| Interest expense | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | +15.3% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | 0.0 | 1.3 | 1.4 | 0.5 | (1.6) | 0.4 | +121.8% | |
| Pre-tax income | (1.5) | (1.7) | (1.4) | (1.7) | (3.8) | (3.0) | +20.7% | |
| Income tax | (0.0) | (0.4) | (0.0) | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.5) | (1.3) | (1.4) | (1.8) | (3.4) | 10.1 | +399.1% | |
| Discontinued operations | 0.0 | (0.2) | 0.3 | (0.0) | 0.4 | 13.1 | +3142.9% | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.01) | (0.01) | (0.01) | (0.01) | (0.02) | 0.03 | +273.1% | |
| EPS, diluted (per share) | (0.01) | (0.01) | (0.01) | (0.01) | (0.02) | 0.03 | +273.1% | |
| EBITDA | (1.5) | (2.7) | (4.2) | (2.3) | (2.1) | (3.0) | −40.6% | |
| Depreciation & amortization | 0.1 | 0.4 | (0.1) | (0.0) | 0.0 | 0.0 | +31.6% | |
| Weighted average shares (shares) | 153,380,000 | 173,825,000 | 188,432,000 | 188,548,000 | 193,211,503 | 247,468,893 | +28.1% | |
| Weighted average diluted shares (shares) | 153,380,000 | 173,825,000 | 188,432,000 | 188,548,000 | 193,211,503 | 247,468,893 | +28.1% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in GBP.
